Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10349761 | 0.86 | MEN1 (0.42) | MEN1KMT2A | |
| SCHEMBL17133916 | 0.82 | MEN1 (0.36) | MEN1KMT2A | |
| SCHEMBL1560823 | 0.78 | — | — | |
| SCHEMBL159206 | 0.76 | MAOA (0.44) | — | |
| SCHEMBL13618845 | 0.75 | MEN1 (0.70) | MEN1KMT2A | |
| SCHEMBL28037506 | 0.75 | MEN1 (0.62) | MEN1KMT2AMMP9MMP13 | |
| SCHEMBL181108 | 0.75 | MEN1 (0.70) | MEN1KMT2A | |
| SCHEMBL242001 | 0.75 | MEN1 (0.56) | MEN1KMT2AMMP9MMP13EGFR | |
| Benzene SCHEMBL28469748 | 0.75 | MEN1 (0.70) | MEN1KMT2A | |
| SCHEMBL27636919 | 0.75 | MAOB (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1622610-B1 | 1-(2H-PYRAZOL-3-YL)-3-{4-[1-(BENZOYL)-PIPERIDIN-4-YLMETHYL]-PHENYL}-UREA DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF P38 KINASE AND/OR TNF INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS | AVENTIS PHARMA INC (US) | 2006-12-20 | — | — | EP | claimed |
| EP-4107151-A1 | HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | Bayer Aktiengesellschaft (DE) | 2022-12-28 | — | — | EP | disclosed |
| CN-106057722-B | Film for flip chip type semiconductor back surface and dicing tape-integrated film for semiconductor back surface | 日东电工株式会社 | 2019-03-08 | — | — | CN | disclosed |
| CN-105355975-B | electrolyte and lithium ion battery including the electrolyte | 宁德新能源科技有限公司 | 2018-08-21 | — | — | CN | disclosed |
| CN-105261789-B | electrolyte and lithium ion battery including the electrolyte | 宁德新能源科技有限公司 | 2018-07-27 | — | — | CN | disclosed |
| US-20180108947-A9 | ELECTROLYTE AND LITHIUM-ION BATTERY CONTAINING THE SAME | NINGDE AMPEREX TECHNOLOGY LTD. (CN) | 2018-04-19 | — | — | US | disclosed |
| CN-107887320-A | Film for flip chip type semiconductor back surface and dicing tape-integrated film for semiconductor back surface | 日东电工株式会社 | 2018-04-06 | — | — | CN | disclosed |
| CN-105070947-B | Electrolyte and the lithium ion battery including the electrolyte | 宁德新能源科技有限公司 | 2017-07-14 | — | — | CN | disclosed |
| US-20170084956-A1 | ELECTROLYTE AND LITHIUM-ION BATTERY CONTAINING THE SAME | Amperex Technology Limited (CN) | 2017-03-23 | — | — | US | disclosed |
| CN-105355975-A | Electrolyte solution and lithium ion battery comprising same | NINGDE AMPEREX TECHNOLOGY LTD | 2016-02-24 | — | — | CN | disclosed |
| CN-102906198-A | Curable composition, cured product, and method for using curable composition | LINTEC CORP | 2013-01-30 | — | — | CN | disclosed |
| EP-1893605-A2 | SAMINOPYRIMIDINE DERIVATES WITH TIE2 INHIBITING ACTIVITY | AstraZeneca AB (SE) | 2008-03-05 | — | — | EP | disclosed |
| EP-1863805-A1 | PYRIMIDINE COMPOUNDS HAVING TIE2 (TEK) INHIBITORY ACTIVITY | AstraZeneca AB (SE) | 2007-12-12 | — | — | EP | disclosed |
| EP-1848715-A1 | COMPOUNDS HAVING TIE2 (TEK) INHIBITORY ACTIVITY | AstraZeneca AB (SE) | 2007-10-31 | — | — | EP | disclosed |
| EP-1846399-A1 | PYRIMIDINE COMPOUNDS HAVING TIE2 (TEK) INHIBITORY ACTIVITY | AstraZeneca AB (SE) | 2007-10-24 | — | — | EP | disclosed |
| WO-2006103449-A2 | SAMINOPYRIMIDINE DERIVATES WITH TIE2 INHIBITING ACTIVITY | ASTRAZENECA AB (SE) | 2006-10-05 | — | — | WO | disclosed |
| WO-2006082373-A1 | PYRIMIDINE COMPOUNDS HAVING TIES (TEK) INHIBITORY ACTIVITY | ASTRAZENECA AB (SE) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006082404-A1 | COMPOUNDS HAVING TIE2 (TEK) INHIBITORY ACTIVITY | ASTRAZENECA AB (SE) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006082371-A1 | PYRIMIDINE COMPOUNDS HAVING TIE2 (TEK) INHIBITORY ACTIVITY | ASTRAZENECA AB (SE) | 2006-08-10 | — | — | WO | disclosed |
| EP-0411423-A2 | Curable dielectric polyphenylene ether-polyepoxide compositions | GENERAL ELECTRIC COMPANY (US) | 1991-02-06 | — | — | EP | disclosed |